Central Trust Company’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,534
Closed -$1K 1253
2019
Q4
$1K Hold
1,534
﹤0.01% 1164
2019
Q3
$0 Sell
1,534
-50
-3% -$27 ﹤0.01% 1224
2019
Q2
$0 Buy
1,584
+50
+3% +$25 ﹤0.01% 1206
2019
Q1
$0 Hold
1,534
﹤0.01% 1207
2018
Q4
$0 Hold
1,534
﹤0.01% 1309
2018
Q3
$0 Hold
1,534
﹤0.01% 1347
2018
Q2
$0 Sell
1,534
-414
-21% -$193 ﹤0.01% 1395
2018
Q1
$0 Sell
1,948
-109
-5% -$44 ﹤0.01% 1391
2017
Q4
$0 Sell
2,057
-600
-23% -$228 ﹤0.01% 1446
2017
Q3
$0 Sell
2,657
-300
-10% -$111 ﹤0.01% 1437
2017
Q2
$1K Buy
2,957
+23
+0.8% +$9 ﹤0.01% 1224
2017
Q1
$1K Sell
2,934
-70
-2% -$31 ﹤0.01% 1134
2016
Q4
$1K Sell
3,004
-1,680
-36% -$569 ﹤0.01% 1153
2016
Q3
$0 Hold
4,684
﹤0.01% 1249
2016
Q2
$0 Hold
4,684
﹤0.01% 1218
2016
Q1
$0 Sell
4,684
-95
-2% -$10 ﹤0.01% 1234
2015
Q4
$0 Hold
4,779
﹤0.01% 1270
2015
Q3
$1K Buy
4,779
+520
+12% +$177 ﹤0.01% 1181
2015
Q2
$2K Hold
4,259
﹤0.01% 1174
2015
Q1
$2K Hold
4,259
﹤0.01% 1152
2014
Q4
$3K Sell
4,259
-2,300
-35% -$1.57K ﹤0.01% 1149
2014
Q3
$3K Sell
6,559
-200
-3% -$97 ﹤0.01% 1138
2014
Q2
$3K Buy
6,759
+14
+0.2% +$7 ﹤0.01% 1123
2014
Q1
$2K Sell
6,745
-200
-3% -$74 ﹤0.01% 1166
2013
Q4
$2K Sell
6,945
-37
-0.5% -$45 ﹤0.01% 1110
2013
Q3
$14K Hold
6,982
﹤0.01% 909
2013
Q2
$13K Buy
+6,982
New +$12.3K ﹤0.01% 878

Central Trust Company's GCVRZ Position: Q1 2020 in Review

Central Trust Company sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,534 shares — an estimated $1K sold.

Central Trust Company first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $14K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Central Trust Company reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Central Trust Company sold 1,534 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
  • Central Trust Company first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
  • Central Trust Company's Sanofi Contingent Value Rights position peaked at $14K in Q3 2013.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Central Trust Company's 13F filing for Q1 2020, filed 17 Apr 2020.